1. Bone marrows from neuroblastoma patients: An excellent source for tumor genome analyses. Issue 3 (28th October 2014) Authors: Abbasi, M. Reza; Rifatbegovic, Fikret; Brunner, Clemens; Ladenstein, Ruth; Ambros, Inge M.; Ambros, Peter F. Journal: Molecular oncology Issue: Volume 9:Issue 3(2015:Mar.) Page Start: 545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1). Issue 30 (20th October 2021) Authors: Bellini, Angela; Pötschger, Ulrike; Bernard, Virginie; Lapouble, Eve; Baulande, Sylvain; Ambros, Peter F.; Auger, Nathalie; Beiske, Klaus; Bernkopf, Marie; Betts, David R.; Bhalshankar, Jaydutt; Bown, Nick; de Preter, Katleen; Clément, Nathalie; Combaret, Valérie; Font de Mora, Jaime; George, Sal... Journal: Journal of clinical oncology Issue: Volume 39:Issue 30(2021) Page Start: 3377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Human repair‐related Schwann cells adopt functions of antigen‐presenting cells in vitro. Issue 12 (17th August 2022) Authors: Berner, Jakob; Weiss, Tamara; Sorger, Helena; Rifatbegovic, Fikret; Kauer, Max; Windhager, Reinhard; Dohnal, Alexander; Ambros, Peter F.; Ambros, Inge M.; Boztug, Kaan; Steinberger, Peter; Taschner‐Mandl, Sabine Journal: Glia Issue: Volume 70:Issue 12(2022) Page Start: 2361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project. Issue 6 (28th December 2015) Authors: Thompson, Daria; Vo, Kieuhoa T.; London, Wendy B.; Fischer, Matthias; Ambros, Peter F.; Nakagawara, Akira; Brodeur, Garrett M.; Matthay, Katherine K.; DuBois, Steven G. Journal: Cancer Issue: Volume 122:Issue 6(2016) Page Start: 935 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progression. Issue 2 (4th October 2017) Authors: Rifatbegovic, Fikret; Frech, Christian; Abbasi, M. Reza; Taschner‐Mandl, Sabine; Weiss, Tamara; Schmidt, Wolfgang M.; Schmidt, Iris; Ladenstein, Ruth; Ambros, Inge M.; Ambros, Peter F. Journal: International journal of cancer Issue: Volume 142:Issue 2(2018) Page Start: 297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Neuroblastoma in older children, adolescents and young adults: A report from the International Neuroblastoma Risk Group project. Issue 4 (13th September 2013) Authors: Mossé, Yaël P.; Deyell, Rebecca J.; Berthold, Frank; Nagakawara, Akira; Ambros, Peter F.; Monclair, Tom; Cohn, Susan L.; Pearson, Andrew D.; London, Wendy B.; Matthay, Katherine K. Journal: Pediatric blood & cancer Issue: Volume 61:Issue 4(2014:Apr.) Page Start: 627 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Proteomics and transcriptomics of peripheral nerve tissue and cells unravel new aspects of the human Schwann cell repair phenotype. Issue 12 (22nd August 2016) Authors: Weiss, Tamara; Taschner‐Mandl, Sabine; Bileck, Andrea; Slany, Astrid; Kromp, Florian; Rifatbegovic, Fikret; Frech, Christian; Windhager, Reinhard; Kitzinger, Hugo; Tzou, Chieh‐Han; Ambros, Peter F.; Gerner, Christopher; Ambros, Inge M. Journal: Glia Issue: Volume 64:Issue 12(2016:Dec.) Page Start: 2133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group. Issue 7 (16th December 2016) Authors: Burchill, Susan A.; Beiske, Klaus; Shimada, Hiroyuki; Ambros, Peter F.; Seeger, Robert; Tytgat, Godelieve A.M.; Brock, Penelope R.; Haber, Michelle; Park, Julie R.; Berthold, Frank Journal: Cancer Issue: Volume 123:Issue 7(2017) Page Start: 1095 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Significance of clinical and biologic features in Stage 3 neuroblastoma: A report from the International Neuroblastoma Risk Group project. Issue 11 (7th July 2014) Authors: Meany, Holly J.; London, Wendy B.; Ambros, Peter F.; Matthay, Katherine K.; Monclair, Tom; Simon, Thorsten; Garaventa, Alberto; Berthold, Frank; Nakagawara, Akira; Cohn, Susan L.; Pearson, Andrew D.J.; Park, Julie R. Journal: Pediatric blood & cancer Issue: Volume 61:Issue 11(2014:Nov.) Page Start: 1932 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The genetic tumor background is an important determinant for heterogeneous MYCN‐amplified neuroblastoma. Issue 1 (22nd March 2016) Authors: Bogen, Dominik; Brunner, Clemens; Walder, Diana; Ziegler, Andrea; Abbasi, Reza; Ladenstein, Ruth L.; Noguera, Rosa; Martinsson, Tommy; Amann, Gabriele; Schilling, Freimut H.; Ussowicz, Marek; Benesch, Martin; Ambros, Peter F.; Ambros, Inge M. Journal: International journal of cancer Issue: Volume 139:Issue 1(2016:Jul. 01) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗